Merck (MRK) Reports In-Line Q4; Guides In-Line
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $146.87 -0.19%
Revenue Growth %: +0.2%
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 122.8M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +0.2%
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 122.8M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q4 EPS of $0.89, versus the consensus of $0.89. Revenue for the quarter came in at $10.1 billion, versus $10.22 billion consensus.
GUIDANCE:
Merck sees FY2017 EPS of $3.72-$3.87, versus the consensus of $3.85.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh
- Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
